|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07C 217/08 | |
| C07C 229/12 |
| (11) | Number of the document | 2788316 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12815878.9 |
| Date of filing the European patent application | 2012-12-07 | |
| (97) | Date of publication of the European application | 2014-10-15 |
| (45) | Date of publication and mention of the grant of the patent | 2019-04-24 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/068450 |
| Date | 2012-12-07 |
| (87) | Number | WO 2013/086322 |
| Date | 2013-06-13 |
| (30) | Number | Date | Country code |
| 201161568121 P | 2011-12-07 | US |
| (72) |
ANSELL, Steven, Michial, CA
DU, Xinyao, US
|
| (73) |
Alnylam Pharmaceuticals, Inc.,
300 Third Street, Cambridge, MA 02142,
US
|
| (54) | BRANCHED ALKYL AND CYCLOALKYL TERMINATED BIODEGRADABLE LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS |
| BRANCHED ALKYL AND CYCLOALKYL TERMINATED BIODEGRADABLE LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS |